Frontlight ResearchEarly access
Metastatic breast cancer trials in Latvia
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in LatviaA Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer
- Where
- Riga
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Rovi Pharmaceuticals Laboratories
See details and how to joinNCT07340658 · EU 2025-524846-85-00